Platelets >= ,/mm^, or >= , in cases of ongoing bone marrow involvement (in either case, these must be independent of transfusion support), documented within days of registration Platelets (Plts) greater than or equal to ,/mm^ (transfusion independent) Platelets >= ,/mm^ transfusion independent (no platelet transfusion one week prior to enrollment) Platelets ? ,/mm^ independent of transfusion support, with no active bleeding Platelets: >= ,/mm^ or >= ,/mm^ if known or suspected bone marrow involvement, independent of transfusion support in either situation Platelets >= ,/mm^ independent of transfusion support, with no active bleeding Platelets: >= ,/mm^ or >= ,/mm^ if bone marrow involvement independent of transfusion support in either situation Platelets >= ,/mcL (transfusion independent) Hemoglobin >= . g/dL in the presence of bone marrow involvement independent of transfusion and/or growth factors within months prior to enrollment Platelet count (transfusion independent) >= ,/mm^ Platelets >= ,/mm^ or >= ,/mm^ in the setting of marrow involvement by disease or splenomegaly due to disease (independent of growth factor or transfusion support) Platelets greater than or equal to ,/mm^ (transfusion independent; no transfusion for >= days prior to study enrollment) Platelets > ,/ul (transfusion independent) Platelet count > ,/mm^; independent of transfusion Platelets > ,/ul (transfusion independent) Platelets >= ,/mm^ (transfusion independent) Platelets (Plts) greater than or equal to ,/mm^ (transfusion independent) Platelets > ,/ul (transfusion independent) Platelets >= ,/mm^ independent of transfusion support, with no active bleeding, and absolute neutrophil count >= /mm^, unless due to disease involvement in the bone marrow Platelets >= ,/mm^ (transfusion independent (except for patients with marrow involvement by disease where there is no blood count requirement, except for platelet count which must be >= , prior to enrollment (can be achieved with transfusion) Platelets >= ,/ mm^ (transfusion independent) Platelet transfusion independent for at least weeks prior to enrollment Platelet count >= ,/mm^ (transfusion independent) Platelets: >= x ^/L, or >= x ^/L if bone marrow involvement and independent of transfusion support for days in either situation Within days prior to signing informed consent: Platelet counts >= ,/mm^ or >= ,/mm^ if bone marrow involvement with lymphoma, independent of transfusion support in either situation Platelets >= ,/mm^ (transfusion independent) Platelet count >= , mm^ independent of transfusion support Platelets >= x ^/L (must be independent of platelet transfusion) Platelets >= ,/mcL (transfusion independent) within two weeks prior to enrollment Platelet count < , cells/mm^ ( x ^/L) independent of transfusion support Platelet count >= ,/ mm^ (transfusion independent for > days) Platelets ?,/mm independent of transfusion Platelets ?,/mm independent of transfusion Platelets > ,/u (transfusion independent); patients with bone marrow involvement are eligible provided they meet these criteria Platelet count >= ,/mm^ or >= ,/mm^ if bone marrow involvement independent of transfusion support in either situation Platelet count >= ,/mm independent of transfusion support OR >= ,/mm independent of transfusion\r\nsupport if bone marrow involvement Platelets >= ,/mm^ or >= ,/mm^ if bone marrow involvement independent of transfusion support in either situation Transfusion independent Platelet count >= , cells/mm^ ( x ^/L) independent of transfusion within days of screening Hemoglobin >= g/L independent of transfusion Platelet count >= , cells/mm^ ( x ^/L) independent of transfusion within days of screening, unless they have significant bone marrow involvement of their malignancy confirmed on biopsy Platelet count >= ,/mm^ (transfusion independent)